Skip to main content
https://pbs.twimg.com/media/GccYpPzW0AAVM-h.jpg
Belimumab, anifrolumab and voclosporin exhibited an increase in claims from 2017-2022 for #SLE Belimumab ~ 600% increase!! @RheumNow #ACR24 abst#1259 https://t.co/norl1xk2KF
Bella Mehta
17-11-2024
×